Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI-2)
Long Study Name: Alzheimer’s Disease Neuroimaging Initiative 2
Study Type: Memory
Study Purpose
The ADNI 2 studywill look at the usefulness of imaging studies and biomarker tests, together with measurements of memory, thinking and daily functioning, in the future conduct of studies that will focus on the identification and treatment of Alzheimer’s disease at an early stage. This study aims to produce data to be stored for these kinds of future research studies.
Study Design
- MRIs at baseline visit, month 3, 6, 12 and 24
- Positron Emission Tomography (PET) scans at baseline visit, month 24 and 48
- Blood draw at screening, baseline visit, month 6, 12, 24, 36 and 48
- Spinal fluid samples at baseline visit, month 24 and 48
Study Qualifications
- Age: 55-90
- Mild/moderate memory and thinking problems, a diagnosis of early Alzheimer’s disease or no memory complaints *
- *To screen for the no memory complaints group participant must be over 70 years old*
- A study partner who can come to clinic visits with you
- Willing to undergo all study procedures including imaging and lumbar puncture
Study Duration
54 months
Study Benefits
- Memory and medical screenings at no cost to you
Study Contact
If you are interested in participating in ADNI 2, call 713-8477 or email lgordine@wakehealth.edu